Status | Study |
Recruiting |
Study Name: Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma Condition: Ewing's Sarcoma Date: 2013-02-21 Interventions: Drug: Standard treatment (as per protocol ISG SSG III) |
Withdrawn |
Study Name: Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients Condition: Ewing's Sarcoma Date: 2012-11-19 Interventions: Radiation: External Beam Radiotherapy |
Completed |
Study Name: Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma Condition: Ewing's Sarcoma Date: 2012-04-18 Interventions: Drug: Olaparib 400mg PO BID Continuous Other Name: A |
Active, not recruiting |
Study Name: Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults Condition: Ewing's Sarcoma Date: 2011-06-30 Interventions: Drug: Chemotherapy |
Recruiting |
Study Name: Study in Localized and Disseminated Ewing Sarcoma Condition: Ewing's Sarcoma Date: 2009-09-30 Interventions: Drug: Zoledronic acid |
Completed |
Study Name: Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment Condition: Sarcoma, Ewing's Date: 2009-01-15 |
Terminated |
Study Name: Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) Condition: Ewing's Sarcoma Date: 2007-12-05 Interventions: Drug: VCR, CTX, ADM; IFO, VP-16 VCD: VCR 2 mg d1, CTX 1200 mg/m2 d1, Mesna 240 mg/m2 tid d1, ADM 75mg/m2 |
Completed |
Study Name: Aerosol L9-NC and Temozolomide in Ewing's Sarcoma Condition: Ewing's Sarcoma Date: 2007-06-26 Interventions: Drug: Temozolomide Cycle 2, Do |
Completed |
Study Name: Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma Condition: Non-Metastatic Ewings Sarcoma Date: 2006-06-19 |
Terminated |
Study Name: Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients Condition: Ewing's Sarcoma Date: 2002-05-29 Interventions: Drug: Vincristine 2.0 mg/m^2 ( |